cartilage promoting TGF-beta modulator (Arcarios)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecartilage promoting TGF-beta modulator (Arcarios)
Drug Alias NameBone diseases/osteoarthritis therapeutic program (Arcarios)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 modulators
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArcarios
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArcarios
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A